Skip to main content
Sai Parenteral's Limited logo

Sai Parenteral's Limited — Investor Relations & Filings

Ticker · SAIPARENT ISIN · INE0H9F01037 LEI · 984500ABF36AF1C83D64 BSE.NS Manufacturing
Open in API
Filings indexed 27 across all filing types
Latest filing 2026-05-29 Call Transcript
Country IN India
Listing BSE.NS SAIPARENT

About Sai Parenteral's Limited

https://www.saiparenterals.com/

Sai Parenteral's Limited specializes in the development, manufacture, and distribution of sterile injectable formulations. The company's core operations focus on a diverse portfolio of parenteral products, including Small Volume Parenterals (SVP), Large Volume Parenterals (LVP), and cephalosporin dry powder injections. Its technical capabilities extend to liquid vials, ampoules, and lyophilized products across multiple therapeutic categories such as anti-infectives, analgesics, and critical care. Utilizing advanced manufacturing infrastructure that complies with Good Manufacturing Practices (GMP), the company provides integrated contract development and manufacturing services (CDMO) alongside its proprietary product range. The organization emphasizes high-quality aseptic processing and formulation stability to meet the requirements of global healthcare providers and institutional markets.

Recent filings

Filing Released Lang Actions
Earnings Call Transcript
Call Transcript Classification · 95% confidence The document provides the full text transcript of Sai Parenterals Limited’s Q4 & FY ’26 earnings conference call, including moderator introduction, management remarks, and Q&A. This matches the definition of a Call Transcript (full transcript of an earnings call).
2026-05-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is a detailed transcript of an earnings conference call for Q4 & FY ’26, introduced as “Transcript of Earnings call held on 27.05.2026” and contains the full CEO/CFO presentation and Q&A format. This matches the definition of a Call Transcript (CT).
2026-05-29 English
Bagging/Receiving of orders/contracts
Regulatory Filings Classification · 92% confidence The document is a compliance disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2018, informing the stock exchanges of a significant business event (receipt of a purchase order). It does not contain financial statements, voting results, management changes, or other specialized report content. This type of announcement falls under general regulatory announcements or compliance filings, which corresponds to the Regulatory Filings category (RNS).
2026-05-28 English
Receipt of Order
Regulatory Filings Classification · 80% confidence The document is a stock exchange filing under SEBI (LODR) Reg. 30 disclosing a significant purchase order. It does not contain financial statements or constitute an earnings release, interim report, or any other specific report type; instead it is a mandatory regulatory disclosure of a material event. It therefore falls into the fallback ’Regulatory Filings’ category.
2026-05-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Report Publication Announcement Classification · 75% confidence The document is a brief announcement under SEBI LODR Regulation 30 informing exchanges that the audio recording of the post-earnings conference call for Q4 and year ended 31 March 2026 is now available via a link. It contains no financial results or substantive analysis, but merely states that the recording has been published online. Under the “menu vs meal” rule, this is not the earnings release itself but an announcement of publication, matching the definition of a Report Publication Announcement (RPA) rather than a full Earnings Release or Call Transcript.
2026-05-27 English
Audio recording
Regulatory Filings Classification · 85% confidence The document is a brief letter notifying stock exchanges that the audio recording of the company's Q4/year-end earnings call is now available online under SEBI LODR Regulation 30. It contains no financial statements, no presentation slides, no transcript text, and no detailed report itself—simply a regulatory announcement of material availability. This does not fit as a full Earnings Release (ER), Call Transcript (CT), or Investor Presentation (IP), but is a miscellaneous regulatory disclosure. Thus it falls into the catch-all Regulatory Filings category (RNS).
2026-05-27 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.